The current state, opportunities and challenges for upscaling private investment in biodiversity in Europe

Main

Biodiversity globally continues its trajectory of long-term decline1. One of the many transformative changes required to reverse this trend and achieve global conservation goals is to address vast mismatches between the level of investment in nature conservation and restoration, and current spending on conservation and perverse government subsidies that incentivize further declines2,3,4. Addressing these economic drivers and enablers of biodiversity loss and recovery is central to the Kunming-Montreal Agreement, with targets 14, 15, 16, 18 and 19 all targeting harmful subsidies, the need of businesses and financial institutions to assess and address their impacts and dependencies on nature and upscaling investment. Public funding for conservation is not growing at close to the rates required to address biodiversity loss5,6. Therefore, in the Kunming-Montreal agreement and prevailing policy discourse7,8,9,10,11,12, there is a strong emphasis on upscaling private investment in conservation and restoration, through “Leveraging private finance, promoting blended finance … green bonds, biodiversity offsets and credits (Target 19)”. However, mechanisms for attracting private investment into nature conservation and restoration remain controversial and understudied12,13,14.

Nowhere is this more apparent than in Europe (including the United Kingdom), perceived as a global leader in sustainability policy15, put into operation through ambitious policies to address biodiversity declines such as the Green Deal, EU Forest Strategy and EU Nature Restoration Law. However, there is little research into private investment in nature in Europe16. A recent global review of empirical studies into incentive mechanisms for forest restoration found zero studies from Europe17 and the Biodiversity Finance Initiative of the United Nations Development Programme, a leading database on biodiversity finance instruments globally, contains no schemes from Europe18. Previous work on investors’ attitudes has focused largely on exploring their motivations for engagement and on investments from institutions in the global north into the global south, with little on investments domestically or within Europe19. Here we address that gap by first reviewing the current state of biodiversity finance in Europe, then presenting the results of three focus group discussions and 25 semistructured interviews with biodiversity finance experts (23 in leadership roles in their organizations) across Europe investigating the barriers and opportunities for upscaling private investment in nature.

Overview of biodiversity finance in Europe

Europe (alongside Latin America) is currently the world region that spends least on biodiversity protection as a percentage of its national budgets globally (an estimated 0.1%)2. Analysing budget data, the European Commission estimates that a total €144 billion was spent on biodiversity in the European Union (EU) from 2014 to 2019 (ref. 20), although this assessment used an investment tagging approach which is sensitive to subjective classifications21. It includes €70.4 billion from the European Commission for domestic initiatives (mostly via the Common Agricultural Policy which is recognized to have done little to address biodiversity loss22) and €2.2 billion for international projects aimed at global environmental goals. Member states contributed €59.0 billion domestically and €12.9 billion internationally. Extrapolating from these figures, the average annual spending on biodiversity from 2021 to 2030 is estimated at €29.4 billion. However, the EU Biodiversity Strategy for 2030 indicates a projected annual requirement of €48.15 billion, implying an annual shortfall of €18.7 billion from 2021 to 2030. In the United Kingdom, the public sector spends approximately £700 million per year on conservation (0.031% of gross domestic product, down from 0.037% in 2008/9)6,23, with a recent industry-led assessment suggesting a biodiversity finance shortfall of approximately £5.6 billion per year24.

Biodiversity is typically conceptualized as a public good, subject to market failures (or ‘cost-shifting’ in ecological economics25) because its value for society is not captured in conventional markets and is therefore not effectively internalized into the prices of goods and services26. However, biodiversity underpins the ecosystem services upon which the economy depends, and therefore the loss of biodiversity represents a risk to economic activity27,28. This underlies efforts to persuade businesses and the financial sector that nature loss represents a material risk, and is therefore worthy of private investment. Historically dominant motivations for private investment in nature have been investing to address risks (including supply chain risks, regulatory risks and reputational risks)29, for corporate social responsibility, marketing purposes or investing in carbon offsets for organizational net-zero strategies19. However, incentives facing organizations and investors are changing as a result of a rapidly evolving regulatory landscape and emerging voluntary initiatives at global, European and national scales (Table 1).

Table 1 A sample of key legislative and voluntary drivers of potential increases in private investment in nature conservation/restoration in Europe
Full size table

A precondition for attracting return-seeking private investment into nature conservation is that the conservation or land management activities delivered through that investment must generate cashflows or prevent costs30,31. Financing instruments and strategies for investing in biodiversity-related outcomes are proliferating rapidly3,7,30,31,32,33,34. These include the growing number of nature-related funds, which are predominantly focused on the generation of market goods in theory associated with biodiversity cobenefits (that is, agriculture or forestry)35, green bonds36 and emerging mechanisms such as biodiversity credits37. However, ensuring that these private investment strategies are in reality delivering improvements in biodiversity remains extremely challenging38. For example, funds invested in sustainability-certified agriculture or forestry, commonly rely on certification for their biodiversity impacts, despite limited evidence for effectiveness39,40. For green bonds, work analysing how these actually generate revenues has found that often the link between their activities and real-world biodiversity outcomes is tenuous38,41.

In contrast with nature-focused investments, which aim to deliver biodiversity cobenefits most commonly as a biproduct of producing market goods, the last few decades have witnessed a rapid proliferation of instruments for commodifying direct increases in biodiversity or carbon (or both) to create potential revenue streams from delivering improvements in nature. These include the expansion of biodiversity and carbon offsetting market-like mechanisms42,43, perceived as the simplest classes of financial instruments for conservation to upscale3 and are therefore core to the ambitions for conservation funding of many countries8. Although the ecological benefits of these market mechanisms are generally variable44,45, no counterfactual-based evaluations to date have been conducted in Europe16. A suite of countries in Europe now have domestic carbon or biodiversity markets underpinned by the state, with several others encouraging voluntary purchase of biodiversity offsets which is often a precursor to these becoming embedded in legislation (Fig. 1).

Fig. 1: Overview of state-affiliated domestic carbon and biodiversity offset markets in Europe.
figure 1

Markets are those for which information was available in English (Methods). Several national biodiversity offsetting markets are also in development.

Full size image

Results and discussion

From our interviews with 25 biodiversity finance experts across Europe we identified two key themes regarding the opportunities for upscaling private investment: (1) macroeconomic and political factors driving potential increases in both supply and demand of projects for private finance and (2) various sources of innovation and specialized experience that emerge as these markets develop.

Major economic shifts driving private investment

In our sample, the intensification of rhetoric and efforts to upscale private investment in conservation were fundamentally perceived to be driven by increasing public awareness and demand for policies addressing biodiversity loss, coupled with a lack of trust that governments possessed the capacity or political capital required to directly address the problem through increasing public spending on biodiversity conservation. “So we can continue to think and expect that governments will solve our problems, but they don’t. They have consistently proven in the last 50 years of my existence here on Earth, they don’t … so you need to focus on private markets, and you need to make that work” (P2, nature market broker).

Our interviews pointed to a range of potential drivers of incentives for increased demand for investments in conservation. These included the traditional motivations of corporate social responsibility and marketing19, organizational net-zero and nature-positive commitments46, as well as the voluntary and policy drivers outlined above such as the taskforce for nature-related financial disclosure (TNFD) and CSRD. We noted that interviewees did not substantiate the exact mechanisms through which they thought these supportive policies and initiatives were to drive demand for conservation investment47. Interviewees highlighted interactions between these different mechanisms, with voluntary corporate initiatives often seen as a necessary precursor to the adoption of supporting policies in legislation. Risk management was another key driver29,48, with dependencies of companies on nature especially in corporate supply chains perceived as an increasingly powerful lever for making biodiversity loss material to companies and therefore drive demand for nature-related investments. An increasing number of commodification mechanisms and policies were seen to be creating opportunities to derive cashflows from biodiversity improvements (for example, new and increasingly established nature markets such as biodiversity net gain in England), increasing investability.

On the supply side, interviewees noted the increasing regulation and economic pressures on farming, driving a perceived interest from land managers to diversify their income streams and participate in environmental markets. Additionally, interviewees and focus group participants noted interactions between consolidated land ownership and participation in environmental markets, with landholders or organizations with large non-operational landholdings looking to use these markets as opportunities to generate revenues through land ownership.

Opportunities arising from innovation and experience

Alongside large-scale ‘push–pull’ factors, various innovations and the development of experience within the biodiversity finance sector were perceived as key enablers of further upscaling. Technological innovation including advancements in near real-time biodiversity monitoring (interviewees mentioned images taken through smartphones and standardized sampling protocols, bioacoustics, eDNA and remote sensing) were seen as central49. Interviewees believed it would enable demand by increasing buyers’ ability to obtain evidence that their contributions to biodiversity improvements mattered. However, although several project developers and brokers described in detail their technologically enabled data collection strategies, these interviewees did not describe how counterfactuals would be ensured for valid impact detection. Less attention was paid in our sample to additionality than to monitoring.

Other non-technological forms of innovation were also found to be critical. Interviewees alluded to new markets and asset classes taking a long time to develop and reach maturity, and there was a sense of ‘learning by doing’, leading to the generation of new financial innovations and logistical or legal innovations to enable these new investment classes. These included fund aggregation9 and new types of governance structures such as innovative contract designs including ecological conditionalities and insurance to attempt to guarantee the delivery of the biodiversity enhancement underpinning the investments50. Another key element was the development of skilled practitioners with combinations of conservation and finance expertise to broker between the two disciplines51.

The analysis of interviews demonstrate opportunities for upscaling private investment, especially in the context of increasing economic pressures on farming driving increased interest in diversification and rapid industry innovation. However, our interview analysis indicates that key links are still missing between these conceptual opportunities and real investments delivering scientifically credible results. For example, there is a lack of clarity on the tangible relationships between hypothetical demand drivers such as disclosure frameworks and how exactly these would drive increased investment or on how ecological monitoring enables the estimation of impact.

Challenges to upscaling high-integrity investment

Upscaling private investment in nature faces myriad challenges. In our interviews the overarching themes were the lack of highly profitable investment opportunities and inherent mismatches between the perceived realities of risks and uncertainties of doing conservation in practice and the level of risk that private investors are willing to bear. Conservation is subject to many categories of risk38 and for investments in conservation to deliver risk-adjusted returns competitive with other options available to investors, the cashflows from private investments need to be either sufficiently high to justify the risks31,33 or the risks need to be mitigated (for example, derisking via blended finance). Otherwise, as one interviewee stated: “they [financial institutions] have easier ways of making money” (P20, team leader at a multilateral development institution). One recent paper demonstrated for a biodiversity-focused private equity firm, investments which were nominally delivering biodiversity improvements had a mean target internal rate of return of 14.7% and blended finance deals subject to derisking had a mean of 11.9% (ref. 33). This corroborated evidence from our interviews highlighting the very high returns required to justify the risks of investment and a fundamental lack of mechanisms that can deliver sufficiently high revenues. “I would consider us very risk-tolerant investors, very, in the grand scheme of things. And we’re looking at things that others would definitely not look at. But even for us, so many of the projects we see are just … It’s not clear where the revenues are going to come from” (P17, investor).

We identified three subthemes relating to risk in our interviews: risks relating to politics and regulation, risks stemming from the mismatch between the complexity of ecology and the needs of investors, and risks stemming from social perceptions and inequities.

Political and regulatory risk

Interviewees noted that the ecological success of mechanisms for attracting private investment into conservation would require political will and substantial investment in ensuring high-quality governance, just as public-sector-led conservation investment would52; except one interviewee (P2, nature market broker) who felt state intervention would undermine their effectiveness. Nearly all participants noted therefore that the development of market-based approaches for conservation financing are a complement, not a substitute for genuine political will for addressing biodiversity loss; the ecological outcomes of either state-led or private-led investments in conservation outcomes hinge on that same political will31,52. Inconsistent political will to address biodiversity loss translates into widespread regulatory uncertainty, a key barrier to both supply and demand for conservation outcomes and therefore to the certainty of cashflows generated through such investments. On the demand side, investors seek a high degree of confidence that there will be a market for the biodiversity benefits generated so that they can sell commodified biodiversity increases to generate cashflows, but the looming threat of governments weakening or removing legislation that is the driver of this demand was a major driver of risk. On the supply side, this same regulatory uncertainty was perceived as a large barrier to initiating the enrolment of land managers into delivering conservation land management.

Mismatches between finance and ecology

Some conventional critiques around the commodification of nature appeared in our interview dataset of interviews (for example, relating to non-fungibility, unsuitability for some types of biodiversity, emphasis on carbon over biodiversity and risks of greenwashing)53,54,55,56,57,58,59. Beyond these concerns, there were additional risks hindering the upscaling of investment. A main barrier to investment cited by investors was the cost of monitoring and the lack of ecologically realistic metrics to evidence increases in biodiversity51. Therefore, investors often use proxies for signalling the biodiversity value of the investment, which might be some form of sustainability certification in the case of agriculture or forestry-related funds35 or biodiversity or carbon metrics aligned with offset certification schemes or national legislation. However, periodic impact evaluations demonstrate that many of the proxies on which they rely often overstate the contributions of these investments to enhancing nature16,39,40,55,60,61. The lack of accepted metrics is a barrier, as interviewees noted, because even well-intentioned purchasing of biodiversity or carbon outcomes using a commodification mechanism or key performance indicators, may present a reputational risk if subjected to public criticism. Participants and focus groups highlighted that carbon credits were by far the main well-developed bankable revenue streams to date, presenting challenges as the kinds of projects and ecologies optimizing for carbon were misaligned with those optimizing for biodiversity.

Additionally, interviewees noted both spatial and temporal mismatches between conservation and the needs of investors. Temporally, conservation was perceived as requiring large up-front investments for uncertain long-term payoffs11, a challenge both because of uncertainties regarding the long-term potential revenues from the investment, and because enroling in selling biodiversity-related outcomes meant land managers would have to forgo their existing revenue streams in the short run, reducing their incentives to enrol. One interviewee noted that this alone meant such projects were probably better matched to receiving non-commercial, long-term public investment. Spatially, interviewees noted that areas of high biodiversity value tend to be located in areas of low human pressure and weak institutions, highlighting that these are the very places where institutions are probably too weak to give investors confidence62 (in the context of European investments in the global south).

Risks from social perceptions and inequities

Interviewees and focus groups noted that those best positioned to take advantage of the opportunities created by upscaling private investment opportunities were institutions with rights over key limiting factors, such as land, or previous experience of social and environmental management for large land-based projects, such as businesses with large non-operational estates; therefore interviewees acknowledged that expanding biodiversity-related investment opportunities have the potential to exacerbate pre-existing inequities. Engagement with local communities at project sites was consistently mentioned by project developers as something that was a ‘nice-to-have’, but resource shortages frequently meant that these activities were deprioritized beyond just satisfying the basic requirements of legislation or accreditation schemes. On the other hand an investment advisor (P5) argued that effective social engagement was an essential risk management tool, as they perceived effective management of social risks to correlate with the good governance required to address other project risks. Additionally, interviewees recognized that inequities may pose a reputational risk to the credibility of these markets themselves through public opinion, especially in the context of blended finance, in cases where public funding backed by taxpayers would be used to derisk investments for financial institutions63.

The role of public policy

The role of public policy was emphasized by all interviewees. A diversity of views were represented, from perceptions of government as the stifler of market innovation and real action to address biodiversity loss (P2, nature markets broker), to government’s emphasis on scaling up private investment being a ‘symbolic instrument’42 designed to impose minimal disruption and ultimately legitimize prevailing unsustainable business practices (P19, director of a sustainable finance non-governmental organization (NGO)), through to cautious optimism about the attempts of public policy to internalize biodiversity into business and investment decisions contingent on high-quality governance and enforcement (most participants across all stakeholder groups). We identified two core themes: recognizing biodiversity finance as just one small part of the conservation puzzle and identifying that public policy is the key enabler of biodiversity finance. Public policy is presented as the creator of these private investment opportunities yet also their major threat.

Upscaling private finance no substitute for regulation

Interviewees from across all stakeholder groups frequently caveated their expectations around upscaling biodiversity finance by situating it as just one piece of the public policy landscape required to address biodiversity loss. They reiterated the public good nature of biodiversity and the challenge in commodifying most types of biodiversity, and therefore highlighted that public investment remained essential. They recognized opportunities for improving the effectiveness of public investment, including through results-based budgeting. Interviewees emphasized the importance of governments strengthening regulations to prevent biodiversity loss, even arguing that this would help create more opportunities for investors as profitable innovation would be required to overcome constraints created through direct regulation of ecological harms64,65: “So there’s a set of things that should just be banned in my view, and that will really help because it’ll help investors. It will drive up demand for, for example, products that can revitalize highly degraded soil. Why is there less demand for that? Because there is still an option of additional conversion across the world” (P17, investor). This investor-proposed perspective is notable for highlighting that regulation can be a source of innovation rather than merely an economic constraint64,65.

Interviews identified many policies that could be enacted to both address biodiversity loss and facilitate the development of private investment opportunities, including improved data transparency on land management activities66, changes in taxation regimes, financial regulation and supervision67 and investment in biodiversity-related state capacity and skills68 (Supplementary Note).

Public policy as enabler of upscaling and its own worst enemy

Public policy was perceived as the dominant driver of opportunities for investing in nature. Through the creation of biodiversity-related markets, public institutions were framed as the mediators of the outcomes of private finance through the design of well-designed commodification mechanisms that would be aligned with delivering positive outcomes coupled with effective enforcement. Additionally, public funding was seen as necessary to catalyse market opportunities through direct subsidies for projects attempting to enter nascent nature markets and derisking investments in these projects. These perspectives challenge the view that there is a dichotomy between public and private biodiversity finance—substantial public investment in creating, governing and stimulating demand for the markets that public policy itself created was perceived as fundamentally essential: “That is [a change] you’ve got to instigate that at a system level. I don’t think again, it’s one that’s going to happen organically within our economy on its own. Our economy, every economic actor plays according to the existing rules of the game. And yes, some innovation happens that changes that and pushes people on and makes things move. But, ultimately they’re constrained by the operating environment within which they are, within which they exist … And, I think the only force that can fundamentally shift that reality is through the role of the state” (P16, team lead at international eNGO).

Given the overwhelming role of public policy, effective governance and well-coordinated regulations were viewed as critical. However, interviewees and focus groups highlighted fundamental tensions between different public policies that appear to both stimulate private investment opportunities and suppress them. One key tension related to the need for access to land to implement projects for nature markets and public policy as a major barrier to land acquisition or enrolment. Nature investment requires the enrolment of land, yet in some jurisdictions restrictions on using public money to purchase land meant that nature investment projects that included land acquisition as part of their conservation management were unable to access public funding or support, preventing projects from proceeding9. Additionally, agricultural subsidies were perceived as a major barrier to enroling land in conservation management. In providing land managers with stable public-policy-derived incomes, enrolment in nature projects must deliver a business case that exceeds the opportunity cost, which spans not just the revenues from subsidies but also the long-term stability of those payments. Subsidies were perceived to be internalized into land prices, increasing the value of land, reducing the viability of privately funded conservation management. On one hand, public policy aims to create and scale nature markets; on the other, through the subsidy system governments invest in its main competition for land: “… the people who are really going to be making money from this are the ones with the most limiting factor in the whole system, which is land” (P24, team lead at conservation charity).

A second key tension identified was between the derisking being demanded from governments to help address the uncertainties facing investors and governments being one of the key causes of these uncertainties. Political and regulatory uncertainty increases risk for investors, as does the uncertainty of how well these markets will be enforced in practice and therefore whether investors will end up investing in something that is later exposed as being non-compliant, highlighting the importance of consistent and long-term policy signals and regulatory certainty for upscaling markets.

Last, a critical subtheme was poor coordination between different sources of finance (that is, non-return-seeking grants and subsidies and private finance opportunities) that leads to competition between existing sources of funding, with projects having a preference for non-return-seeking grants9. A lack of coordination can lead to projects, which were strong candidates for return-seeking finance ending up funded by direct grants, drawing potential supply out of markets. This highlights the need for better coordination at landscape scales between funding sources to direct different kinds of financing into different projects based on the ecological characteristics of the projects and their suitability for funding through existing market-based funding mechanisms.

Our study has generated new insights and reinforced existing ones, presenting a snapshot of the drivers and policies underpinning private investment in biodiversity in Europe. The private investment ecosystem is evolving and maturing, underpinned by perceived macroeconomic opportunities that prompt land managers to investigate diversifying into generating biodiversity-related commodities. However, we still identify missing links between hypothesized demand drivers and real investments in biodiversity, such as incomplete conceptualizations of how biodiversity disclosure might cause increased private investment, a severe lack of opportunities to derive cashflows from biodiversity and myriad risks including the under-explored risk arising from the perception that biodiversity markets may exacerbate inequities and privilege those owning land.

This study reinforces that public policy is the critical enabler of private investment, through creating the commodification mechanisms that underpin markets, regulation to prevent enrolment of poor projects and then even stimulating demand through derisking and blended finance to bring nature investment projects up to the very high-risk-adjusted returns required to attract mainstream private investment. Therefore, although these markets have arisen as a ‘second-best’ solution to better direct public regulation and investment in biodiversity-related public goods, their success remains contingent on similar political will and substantial public investment. It remains an open question whether solving the nature finance gap through the expansion of public policy-derived private investment opportunities or direct public policy and public investment is the more cost-effective solution to achieving biodiversity funding goals69.

This work highlights many avenues for future research, including empirical explorations of the interactions between agricultural subsidies and nature markets, the appropriate role of derisking in nature markets to maximize value to society and how to coordinate across different funding streams to direct the right kinds of capital into the right places to deliver on overarching biodiversity goals.

Methods

Review of national biodiversity and carbon offset policies

No comprehensive up-to-date review exists for national voluntary carbon markets (VCM) and biodiversity offset markets in Europe. Consequently, to obtain information on national policies, it was necessary to use a variety of data sources identified through a search of scientific and grey literature using Google and Google Scholar. A key limitation of these methods is that only sources in English and translated webpages were used.

National VCMs

To investigate domestic nature-based VCMs in Europe, we conducted a literature review. We searched the Carbon Gap Interactive Policy Tracker and World Bank Carbon Pricing70 reports supplemented by an online search of both scientific and grey literature on each European country, using keywords and phrases: ‘VCM’, ‘voluntary carbon market’, ‘national carbon market’, ‘domestic carbon market’, ‘carbon offset market’, ‘voluntary carbon offsets’ and ‘national carbon offsets’. For each country, a search was conducted first in English. Following this, the same searches were repeated in the national language(s) of each country, using Google Translate to translate the key phrases ‘carbon offset market’ and ‘biodiversity offset market’. We searched relevant sources identified for reference to a domestic-state-supported VCM involving the sale of carbon credits delivered through nature-based climate solutions. VCMs are included where credits are delivered through restoration of any type of natural ecosystem. Where a domestic VCM was identified, we determined where possible: whether the market operates at a national or subnational level; whether the market is in an operational or developmental stage; the ecosystem type(s) through which carbon credits are delivered. Market-based mechanisms operating at an international level or those involving sale of non-nature-based credits in a compliance emissions trading scheme (ETS), are not included in this review.

Compliance emissions trading schemes

In addition to national VCMs, countries may sell carbon credits on the international voluntary carbon market. EU Member States, alongside Iceland, Liechtenstein and Norway, are also covered by the compliance cap-and-trade market of the EU ETS. Select countries also use ETS operating at a national level, including the non-EU members United Kingdom and Switzerland, not covered by the EU ETS. Data on European countries using a national ETS were obtained through the most recent World Bank Carbon Pricing report70.

Biodiversity offset markets

To deduce which European countries use biodiversity offset markets, we collated information in previous reviews71,72,73. Following the initial scoping search, scientific and grey literature was identified for each European country, using keywords and phrases: ‘ecological compensation’, ‘biodiversity offsetting’, ‘biodiversity compensation’, ‘ecological compensation market’, ‘biodiversity offset market’, ‘habitat banking’, ‘biodiversity banking’ and ‘biodiversity credits’. Relevant literature identified included: peer-reviewed scientific papers, policy documents, organizational webpages (NGO and government) and book chapters71.

We identified countries with biodiversity compensation policies, then identified whether there was evidence for the use of an offset market within this policy: a market-based mechanism involving sale of credits generated through restoration of biodiversity. We included markets that were operational and not those that are development (for example, Finland74). We noted circumstances where financial compensation is required for losses of biodiversity, but is directed towards a government or centralized body, rather than towards purchase of credits in an offset market.

Development of interview guide

The authors began with a predetermined overarching question set by the terms of their grant agreement (EU Horizon 2020 project SUPERB (systemic solutions for upscaling of urgent ecosystem restoration for forest-related biodiversity and ecosystem services)): “what are the opportunities and barriers to the upscaling of restoration finance in Europe?”. Three workshops were organized in Cambridge (United Kingdom), Amsterdam and Copenhagen in 2022–2023 with high-level biodiversity finance stakeholders from predominantly financial institutions and other biodiversity finance-related knowledge firms and environmental NGOs with a focus on private conservation finance to gain preliminary insights and identify key questions for inclusion in the semistructured interview guide. These focus groups highlighted the critical enabling role of public policy in biodiversity finance, leading to the inclusion of a section on public policy in the interviews. The interview guide was then developed and refined following input from members of the authorship team. We developed slightly different interview guides for generalist biodiversity finance experts and investors, with the interview with investors focused on generating more detailed insights on the specific decision-making underpinning investments in conservation and their barriers (interview guides in Supplementary Note).

Interviews

We identified relevant experts to interview through existing knowledge of influential individuals in biodiversity finance networks (acquired through coauthors’ participation in various European international biodiversity finance-related research projects, business-biodiversity fora including the Danish Nature Fund, advisory roles to the UK government regarding biodiversity net gain), the authors of relevant policy and industry reports and snowball sampling. We approached 34 experts of which 25 accepted our interview requests, spanning investors (5), directors at biodiversity finance knowledge and investment firms (5), finance team leaders or directors within conservation NGOs (5) and multilateral development institutions (4), directors of mixed nature finance-related consortia (2), a senior policy-maker (1), an academic (1), a director of a conservation brokerage/marketplace (1) and a director of a carbon project developer (1). In focus groups, participants perceived that England was the main European hotspot in biodiversity finance practice and innovation as a result of the creation of several new markets in the post-Brexit period of regulatory reform and withdrawal from the EU Common Agricultural Policy, as well as specialisms in financial innovation in the City of London. Therefore, our final sample included interviewees working in the following countries: England (9), the Netherlands (3), Denmark (2), Switzerland (1), Germany (2), France (3), EU-wide roles (4) and the United States (1). Note the explicit research question we were asking related to how to upscale investment, which makes the prior assumption that upscaling of private finance is desirable, and we therefore did not target many dissenting voices in our sample; our interviewees were therefore biased in favour of increasing private investment opportunities and many legitimate opposing views are not represented in our dataset. Interviewees were contacted via email, which included a participant information sheet providing the background and context of the study. Interviews were conducted via Microsoft Teams. Interviewees were asked for permission to record and transcribe interviews and, if permission was not granted, then notes were taken with the interviewees consent. Formal consent was secured orally from all interviewees.

Data analysis

Interviews were transcribed using a mixture of the built-in transcription software of Microsoft Teams and a university-approved transcription services provider; all transcripts were fully pseudonymized and all identifying information or information about their organizations removed from final transcripts. We conducted thematic analysis of interview transcripts, following the sequential process of reading all transcripts (data familiarization), generation of initial codes, identifying themes, code consolidation and recoding and writing the paper alongside recoding and identifying final themes75,76. Most of our analysis was inductive, a bottom-up approach to coding where the researcher identifies a specific question and then identifies all codes in the data that they interpret to be of relevance to answering the question, before coding and theme identification (that is, coding is undertaken as far as possible without conforming to previous theoretical knowledge of the topic). A single subtheme was informed by our previous theoretical understanding (see section on ‘Mismatches between finance and ecology’) as this has been a key focus of the primary analyst’s research7,11,55, and so coding for this subtheme alone would be better described as derived from theoretical (rather than inductive) thematic analysis76. In line with related interview studies19,77, our full thematic framework describing all themes, subthemes and final set of codes is given in Supplementary Note, along with exemplar quotes evidencing each subtheme.

Ethics

This research received ethics approval from the University of Oxford’s Medical Sciences interdivisional ethics committee (Ethics Approval Reference: R83938/RE001).

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

Related Articles

Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects

The muscular system plays a critical role in the human body by governing skeletal movement, cardiovascular function, and the activities of digestive organs. Additionally, muscle tissues serve an endocrine function by secreting myogenic cytokines, thereby regulating metabolism throughout the entire body. Maintaining muscle function requires iron homeostasis. Recent studies suggest that disruptions in iron metabolism and ferroptosis, a form of iron-dependent cell death, are essential contributors to the progression of a wide range of muscle diseases and disorders, including sarcopenia, cardiomyopathy, and amyotrophic lateral sclerosis. Thus, a comprehensive overview of the mechanisms regulating iron metabolism and ferroptosis in these conditions is crucial for identifying potential therapeutic targets and developing new strategies for disease treatment and/or prevention. This review aims to summarize recent advances in understanding the molecular mechanisms underlying ferroptosis in the context of muscle injury, as well as associated muscle diseases and disorders. Moreover, we discuss potential targets within the ferroptosis pathway and possible strategies for managing muscle disorders. Finally, we shed new light on current limitations and future prospects for therapeutic interventions targeting ferroptosis.

Type 2 immunity in allergic diseases

Significant advancements have been made in understanding the cellular and molecular mechanisms of type 2 immunity in allergic diseases such as asthma, allergic rhinitis, chronic rhinosinusitis, eosinophilic esophagitis (EoE), food and drug allergies, and atopic dermatitis (AD). Type 2 immunity has evolved to protect against parasitic diseases and toxins, plays a role in the expulsion of parasites and larvae from inner tissues to the lumen and outside the body, maintains microbe-rich skin and mucosal epithelial barriers and counterbalances the type 1 immune response and its destructive effects. During the development of a type 2 immune response, an innate immune response initiates starting from epithelial cells and innate lymphoid cells (ILCs), including dendritic cells and macrophages, and translates to adaptive T and B-cell immunity, particularly IgE antibody production. Eosinophils, mast cells and basophils have effects on effector functions. Cytokines from ILC2s and CD4+ helper type 2 (Th2) cells, CD8 + T cells, and NK-T cells, along with myeloid cells, including IL-4, IL-5, IL-9, and IL-13, initiate and sustain allergic inflammation via T cell cells, eosinophils, and ILC2s; promote IgE class switching; and open the epithelial barrier. Epithelial cell activation, alarmin release and barrier dysfunction are key in the development of not only allergic diseases but also many other systemic diseases. Recent biologics targeting the pathways and effector functions of IL4/IL13, IL-5, and IgE have shown promising results for almost all ages, although some patients with severe allergic diseases do not respond to these therapies, highlighting the unmet need for a more detailed and personalized approach.

The risk effects of corporate digitalization: exacerbate or mitigate?

This study elaborates on the risk effects of corporate digital transformation (CDT). Using the ratio of added value of digital assets to total intangible assets as a measure of CDT, this study overall reveals an inverse relationship between CDT and revenue volatility, even after employing a range of technical techniques to address potential endogeneity. Heterogeneity analysis highlights that the firms with small size, high capital intensity, and high agency costs benefit more from CDT. It also reveals that advancing information infrastructure, intellectual property protection, and digital taxation enhances the effectiveness of CDT. Mechanism analysis uncovers that CDT not only enhances financial advantages such as bolstering core business and mitigating non-business risks but also fosters non-financial advantages like improving corporate governance and ESG performance. Further inquiries into the side effects of CDT and the dynamics of revenue volatility indicate that CDT might compromise cash flow availability. Excessive digital investments exacerbate operating risks. Importantly, the reduction in operating risk associated with CDT does not sacrifice the potential for enhanced company performance; rather, it appears to augment the value of real options.

Targeting of TAMs: can we be more clever than cancer cells?

With increasing incidence and geography, cancer is one of the leading causes of death, reduced quality of life and disability worldwide. Principal progress in the development of new anticancer therapies, in improving the efficiency of immunotherapeutic tools, and in the personification of conventional therapies needs to consider cancer-specific and patient-specific programming of innate immunity. Intratumoral TAMs and their precursors, resident macrophages and monocytes, are principal regulators of tumor progression and therapy resistance. Our review summarizes the accumulated evidence for the subpopulations of TAMs and their increasing number of biomarkers, indicating their predictive value for the clinical parameters of carcinogenesis and therapy resistance, with a focus on solid cancers of non-infectious etiology. We present the state-of-the-art knowledge about the tumor-supporting functions of TAMs at all stages of tumor progression and highlight biomarkers, recently identified by single-cell and spatial analytical methods, that discriminate between tumor-promoting and tumor-inhibiting TAMs, where both subtypes express a combination of prototype M1 and M2 genes. Our review focuses on novel mechanisms involved in the crosstalk among epigenetic, signaling, transcriptional and metabolic pathways in TAMs. Particular attention has been given to the recently identified link between cancer cell metabolism and the epigenetic programming of TAMs by histone lactylation, which can be responsible for the unlimited protumoral programming of TAMs. Finally, we explain how TAMs interfere with currently used anticancer therapeutics and summarize the most advanced data from clinical trials, which we divide into four categories: inhibition of TAM survival and differentiation, inhibition of monocyte/TAM recruitment into tumors, functional reprogramming of TAMs, and genetic enhancement of macrophages.

Integrated proteogenomic characterization of ampullary adenocarcinoma

Ampullary adenocarcinoma (AMPAC) is a rare and heterogeneous malignancy. Here we performed a comprehensive proteogenomic analysis of 198 samples from Chinese AMPAC patients and duodenum patients. Genomic data illustrate that 4q loss causes fatty acid accumulation and cell proliferation. Proteomic analysis has revealed three distinct clusters (C-FAM, C-AD, C-CC), among which the most aggressive cluster, C-AD, is associated with the poorest prognosis and is characterized by focal adhesion. Immune clustering identifies three immune clusters and reveals that immune cluster M1 (macrophage infiltration cluster) and M3 (DC cell infiltration cluster), which exhibit a higher immune score compared to cluster M2 (CD4+ T-cell infiltration cluster), are associated with a poor prognosis due to the potential secretion of IL-6 by tumor cells and its consequential influence. This study provides a comprehensive proteogenomic analysis for seeking for better understanding and potential treatment of AMPAC.

Responses

Your email address will not be published. Required fields are marked *